On the first point, about the definitions, there is currently a definition in the food and drug regulations of an adverse drug reaction. There is also a definition of a serious adverse drug reaction. So these definitions do currently exist in the food and drug regulations.
On the question about what will come out of all this information, I think there's been a steady increase in the resources that are dedicated to post-market surveillance in Canada in the past five years. There's a commitment to continue to support that.
If you take, for example, the budget of MHPD, it has increased steadily in the past five years. Our scientific and clinical capacity to process this information has almost tripled in the past five years. There is that capacity now to absorb, process, and evaluate more information related to post-market safety issues at Health Canada.